Employees: NN (None)Legal category: 5485Size: PMECreation date: 2014-06-05 (11 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: MONS-EN-BARŒUL (59370), Nord
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE VAUBAN : revenue, balance sheet and financial ratios
PHARMACIE VAUBAN is a French company
founded 11 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in MONS-EN-BARŒUL (59370),
this company of category PME
shows in 2025 a net income positive of 22 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE VAUBAN (SIREN 802760413)
Indicator
2025
2024
2021
Revenue
N/C
N/C
N/C
Net income
21 514 €
16 088 €
1 795 €
EBITDA
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
Revenue and income statement
In 2025, PHARMACIE VAUBAN generates positive net income of 22 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2021-2025: 2 k€ -> 22 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
21 514 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 1141%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 6%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
1141.206%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
6.038%
Solvency indicators evolution PHARMACIE VAUBAN
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2021
2024
2025
Debt ratio
-1430.9
4459.158
1141.206
Financial autonomy
-5.432
1.688
6.038
Repayment capacity
None
None
None
Cash flow / Revenue
None%
None%
None%
Sector positioning
Debt ratio
1141.212025
2021
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Watch+50 pts over 3 years
In 2025, the debt ratio of PHARMACIE VAUBAN (1141.21) ranks in the top 25% of the sector. This ratio measures the weight of debt relative to equity. A high ratio may indicate excessive dependence on external financing.
Financial autonomy
6.04%2025
2021
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Watch
In 2025, the financial autonomy of PHARMACIE VAUBAN (6.0%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 68.54. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
68.543
Liquidity indicators evolution PHARMACIE VAUBAN
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2021
2024
2025
Liquidity ratio
68.825
65.149
68.543
Interest coverage
None
None
None
Sector positioning
Liquidity ratio
68.542025
2021
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Watch
In 2025, the liquidity ratio of PHARMACIE VAUBAN (68.54) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Positioning of PHARMACIE VAUBAN in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE VAUBAN is estimated at
341 752 €
(range 231 914€ - 536 256€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
231k€341k€536k€
341 752 €Range: 231 914€ - 536 256€
NAF 5 année 2025
Valuation method used
Net Income Multiple
21 514 €
×
15.9x
=341 752 €
Range: 231 915€ - 536 257€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE VAUBAN with other companies in the same sector:
The revenue of PHARMACIE VAUBAN is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE VAUBAN profitable?
Yes, PHARMACIE VAUBAN generated a net profit of 22 k€ in 2025.
Where is the headquarters of PHARMACIE VAUBAN ?
The headquarters of PHARMACIE VAUBAN is located in MONS-EN-BARŒUL (59370), in the department Nord.
Where to find the tax return of PHARMACIE VAUBAN ?
The tax return of PHARMACIE VAUBAN is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE VAUBAN operate?
PHARMACIE VAUBAN operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart